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to monitor permeabilized zones in the brain, differentiating between 
transiently and permanently permeabilized brain tissue. 
Materials and Methods: Electroporation (EP) was applied in the rat 
brain in vivo (n=48) to induce cell permeabilization ranging from 
transient to permanent (Figure 1). DW-MRI (human 3T MRI system) was 
acquired 5min, 2h, 24h and 48h after EP. The DWIBS sequence (b-
values: 50, 100, 150, 600, 800, 1000 s/mm2) was applied. ADC and 
kurtosis were derived by polynomial fitting to the series expansion of 
the Stejskal-Tanner expression. Electric field calculations were based 
on the finite element method. 
Results: ADC was significantly increased in the transiently 
permeabilized brain tissue (pooled: P<0.01, 2h: p<0.04), and in the 
more severely permeabilized brain tissue (24h: p<0.03). ADC increase 
in the permanently permeabilized tissue was delayed. Kurtosis was 
increased in both the transiently and permanently permeabilized brain 
tissue (pooled: P<0.01, P<0.02, P<0.00003). Histology showed 
correlation to the ADC and kurtosis changes. Overlay of calculated 
electric field contour on histology samples (Figure 1) confirmed 
transient permeabilization (edema at 300-600 V/cm) and permanent 
permeabilization (lysis and necrosis at 1000-1200 V/cm). 
 
  
Figure 1 Representative histological samples and DW-MRI images of 
both transiently (24h) and permanently permeabilized (48h) zones in 
the brain. The dashed lines show the correspondence between the 
planes. The dashed boxes show the selected regions of interest (ROI).  
Conclusions: Results indicate that DW-MRI is capable of defining 
permeabilized zones in the rat brain, and specifically to differentiate 
between transiently and permanently permeabilized tissues. This 
suggests that DW-MRI may potentially be used for early verification of 
radiation dose delivery to target. Further, DW-MRI may serve as a 
biomarker predicting treatment outcome, based on the severity of 
membrane permeabilization seen immediately after irradiation.  
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Purpose/Objective: In head and neck cancer (HNC) the ability to 
anticipate an individual patient's outcome is very valuable. Diffusion 
weighted MRI (DWI) can characterize the tumor's microstructure and 
might prove a valuable asset in response prediction. With this study 
we wanted to investigate the predictive value of pretreatment ADC 
values in a large patient population and investigate the clinical value 
of such a predictive model. 
Materials and Methods: Between August 2004 and May 2010 161 
patients with pathology proven HNC were included in this study. All 
patients underwent a pretreatment MRI with DWI using six b-values 
(0,50,100,500, 750 and 1000s/mm²). For each tumor, two ADC values 
were calculated using different b-values: ADClow (b:0-50-100s/mm² 
and ADChigh (b500-750-1000s/mm²). The clinical variables included: 
tumor and nodal volume, tumor location and age. Three year disease 
free survival (DFS), locoregionalcontrol (LRC) and distant metastasis 
free survival (DM) were determined using a Kaplan-meier estimate. 
Variables were incorporated into a multivariate competing risk 
analysis for DFS, LRC and DM. The prediction model for DFS was 
validated using the Harrell's c-statistic and by dividing patients in 
three groups based on prognosis. This information was then distilled 
into a nomogram correlating clinical and imaging parameters with 
DFS.  
Results: Median follow-up was 50 months (range 4-86). Atotal of 67 
patients experienced disease recurrence during follow-up (42%).Three 
year DFS, LRC and DM were 60%, 70%and 78% respectively. After 
multivariate analysis tumor volume, nodal volume and ADChigh were 
shown to be significant and independent predictors for DFS. ADChigh 
predicted LRC more strongly, while tumor and nodal volume seemed 
to be more predictive of DM (Table 1.) The Harrell's c-index for the 
prediction model for DFS was 0.62 (0.55-0.96 95% CI). After bootstrap-
based validation the group with the worst prognosis had a DFS 
probability of 44% after 3 years. The remaining two patient groups had 
a DFS probability of 67% and 69% respectively. All parameters were 
put into a nomogram predicting DFS probability (Figure 1). 
 
 
 
 
Conclusions: The pretreatment ADCvalue, derived from high b-values, 
appears to be a strong predictive factor in HNC patients treated with 
radiotherapy. The construction of a predictive model based on the 
combination of functional imaging and clinical parameters might be a 
helpful tool in the process of treatment selection. Adding biological 
and molecular parameters to such a model might further increase its 
performance.  
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Purpose/Objective: To evaluate the utility of 18Fluoromisonidazole 
(FMISO) Positron Emission Tomography (PET) scans performed prior to, 
during and following curative intent radiotherapy (RT) for head and 
neck cancer. 
Materials and Methods: Eighteen prospectively accrued patients (50% 
with oropharyngeal primaries) underwent FMISO PET scans prior to 
